Literature DB >> 28550044

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.

David M Woods1,2, Karrune V Woan1, Fengdong Cheng1,3, Andressa L Sodré1,2, Dapeng Wang1, Yongxia Wu4, Zi Wang1, Jie Chen1,3, John Powers1, Javier Pinilla-Ibarz1, Yu Yu1, Ya Zhang4, Xuefeng Wu4, Xiaoyan Zheng4, Jeffrey Weber1,2, Wayne W Hancock5, Edward Seto3, Alejandro Villagra3, Xue-Zhong Yu6, Eduardo M Sotomayor3.   

Abstract

Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype. Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions. Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression. Experiments using HDAC11 knockout (KO) mice revealed that T cells from these mice displayed enhanced proliferation, proinflammatory cytokine production, and effector molecule expression. In addition, HDAC11KO T cells had increased expression of Eomesodermin (Eomes) and TBX21 (Tbet), transcription factors previously shown to regulate inflammatory cytokine and effector molecule production. Conversely, overexpression of HDAC11 resulted in decreased expression of these genes. Chromatin immunoprecipitation showed the presence of HDAC11 at the Eomes and Tbet gene promoters in resting T cells, where it rapidly disassociated following T-cell activation. In vivo, HDAC11KO T cells were refractory to tolerance induction. HDAC11KO T cells also mediated accelerated onset of acute graft-versus-host disease (GVHD) in a murine model, characterized by increased proliferation of T cells and expression of interferon-γ, tumor necrosis factor, and EOMES. In addition, adoptive transfer of HDAC11KO T cells resulted in significantly reduced tumor burden in a murine B-cell lymphoma model. Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28550044      PMCID: PMC5510785          DOI: 10.1182/blood-2016-08-731505

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

2.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

3.  Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.

Authors:  Lin Gao; Maria A Cueto; Fred Asselbergs; Peter Atadja
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

4.  LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice.

Authors:  Dapeng Wang; Cristina Iclozan; Chen Liu; Changqing Xia; Claudio Anasetti; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-12       Impact factor: 5.742

5.  Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B).

Authors:  Yasuto Araki; Monchou Fann; Robert Wersto; Nan-Ping Weng
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

6.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

7.  Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance.

Authors:  Stephanie R Jackson; Jinyun Yuan; Melissa M Berrien-Elliott; Collin L Chen; Jennifer M Meyer; Maureen J Donlin; Ryan M Teague
Journal:  J Leukoc Biol       Date:  2014-05-13       Impact factor: 4.962

8.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

Review 9.  Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies.

Authors:  Yoichi Imai; Yoshiro Maru; Junji Tanaka
Journal:  Cancer Sci       Date:  2016-11-04       Impact factor: 6.716

10.  Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes.

Authors:  Yohko Kitagawa; Naganari Ohkura; Shimon Sakaguchi
Journal:  Front Immunol       Date:  2013-05-10       Impact factor: 7.561

View more
  23 in total

Review 1.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

2.  Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells.

Authors:  Paramita Chakraborty; Shilpak Chatterjee; Pravin Kesarwani; Krishnamurthy Thyagarajan; Supinya Iamsawat; Annika Dalheim; Hung Nguyen; Shanmugam P Selvam; Patrick Nasarre; Gina Scurti; Gary Hardiman; Nilanjana Maulik; Lauren Ball; Vamsi Gangaraju; Mark P Rubinstein; Nancy Klauber-DeMore; Elizabeth G Hill; Besim Ogretmen; Xue-Zhong Yu; Michael I Nishimura; Shikhar Mehrotra
Journal:  J Biol Chem       Date:  2019-04-10       Impact factor: 5.157

3.  Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma.

Authors:  Jeffrey S Weber; Benjamin A Levinson; Andressa S Laino; Anna C Pavlick; David M Woods
Journal:  Melanoma Res       Date:  2022-06-09       Impact factor: 3.199

Review 4.  Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune Responses.

Authors:  Lanette M Christensen; Wayne W Hancock
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

5.  Cigarette smoke extract modulates Pseudomonas aeruginosa bacterial load via USP25/HDAC11 axis in lung epithelial cells.

Authors:  Chen Long; Yandong Lai; Tiao Li; Toru Nyunoya; Chunbin Zou
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

6.  HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms.

Authors:  Lanzhu Yue; Vasundhara Sharma; Nathan P Horvat; Afua A Akuffo; Matthew S Beatty; Cem Murdun; Christelle Colin; Julia M R Billington; William E Goodheart; Eva Sahakian; Ling Zhang; John J Powers; Narmin E Amin; Que T Lambert-Showers; Lancia N Darville; Javier Pinilla-Ibarz; Gary W Reuther; Kenneth L Wright; Chiara Conti; Jennifer Y Lee; Xiaozhang Zheng; Pui Yee Ng; Matthew W Martin; C Gary Marshall; John M Koomen; Ross L Levine; Amit Verma; H Leighton Grimes; Eduardo M Sotomayor; Zonghong Shao; Pearlie K Epling-Burnette
Journal:  Blood       Date:  2020-01-16       Impact factor: 22.113

Review 7.  The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations.

Authors:  Chenchen Zhao; Yi Zhang; Hong Zheng
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

Review 8.  Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy.

Authors:  Debarati Banik; Sara Moufarrij; Alejandro Villagra
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

Review 9.  Protein acetylation: a novel modus of obesity regulation.

Authors:  Yuexia Liu; Hong Yang; Xuanchen Liu; Huihui Gu; Yizhou Li; Chao Sun
Journal:  J Mol Med (Berl)       Date:  2021-06-01       Impact factor: 4.599

10.  Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model.

Authors:  Lei Sun; Elphine Telles; Molly Karl; Fengdong Cheng; Noreen Luetteke; Eduardo M Sotomayor; Robert H Miller; Edward Seto
Journal:  Life Sci Alliance       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.